Pathways to Prevention: A Policy Discussion on Research & Treatments for Alzheimer’s

More than 5 million Americans currently suffer from Alzheimer’s and, in 2016, the disease will cost the U.S. healthcare system $236 billion. Join The Hill on Thursday, June 23 for a discussion on how policymakers and the healthcare industry can collaborate to find more effective treatments for Alzheimer’s. What developments and information are prompting breakthroughs in disease research? What are the potential pathways to meeting NIH’s 2025 prevention goal?

8:35 AM: Keynote interview with SEN. SHELLEY MOORE CAPITO (R-WV) in conversation with The Hill’s BOB CUSACK

8:55 AM: Sponsor Perspective presented by DAVE RICKS, Senior Vice President & President, Lilly Bio-Medicine, Eli Lilly and Company in conversation with JILL LESSER, President, Women Against Alzheimer’s Network

9:10 AM: Evolving Science & Policy Reforms panel discussion, featuring:
RONALD C. PETERSEN, Ph.D., M.D., Director, Mayo Alzheimer’s Disease Research Center, Mayo Clinic College of Medicine
LORI REILLY, Executive Vice President for Policy & Research, PhRMA
LAURIE RYAN, Ph.D., Chief, Dementias of Aging Branch & Program Director, Alzheimer’s Disease Clinical Trials, National Institute on Aging, National Institutes of Health
WILLIAM THIES, Ph.D., Senior Scientist in Residence, Alzheimer’s Association

9:40 AM: Keynote interview with SEN. ED MARKEY (D-MA) in conversation with BOB CUSACK

10:00 AM: Program concludes

This is event is in in partnership with:
Alzheimer’s Readiness Project

Sponsored by:
Eli Lilly